Parkinson’s disease or multiple system atrophy: potential separation by quantitative susceptibility mapping

Parkinson’s disease or multiple system atrophy: potential separation by quantitative susceptibility mapping

Background: Due to the absence of robust biomarkers, and the low sensitivity and specificity of routine imaging techniques, the differential diagnosis between Parkinson’s disease (PD) and multiple system atrophy (MSA) is challenging. High-field magnetic resonance imaging (MRI) opened up new possibil...

Full description

Bibliographic Details
Main Authors:	Franz Marxreiter, Vera Lambrecht, Angelika Mennecke, Jannis Hanspach, Jelena Jukic, Martin Regensburger, Juergen Herrler, Alexander German, Jan Kassubek, Georg Grön, Hans-Peter Müller, Frederik B. Laun, Arnd Dörfler, Juergen Winkler, Manuel A. Schmidt
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-02-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/17562864221143834

Similar Items

The Effects of an Individualized Smartphone-Based Exercise Program on Self-defined Motor Tasks in Parkinson Disease: Pilot Interventional Study
by: Heiko Gaßner, et al.
Published: (2022-11-01)

The effects of an individualized smartphone-based exercise program on self-defined motor tasks in Parkinson’s disease: a long-term feasibility study
by: Lisa Lützow, et al.
Published: (2023-10-01)

3T vs. 7T fMRI: capturing early human memory consolidation after motor task utilizing the observed higher functional specificity of 7T
by: Silke Kreitz, et al.
Published: (2023-08-01)

Clinical Phenotype Imprints on Brain Atrophy Progression in Parkinson’s Disease
by: David H. Benninger, et al.
Published: (2023-02-01)

DTI analysis in patients with primary open-angle glaucoma: impact of registration on Voxel-Wise statistics.
by: Manuel A Schmidt, et al.
Published: (2014-01-01)

Comparison of Diagnostic Performance and Image Quality between Topup-Corrected and Standard Readout-Segmented Echo-Planar Diffusion-Weighted Imaging for Cholesteatoma Diagnostics
by: Marco Wiesmueller, et al.
Published: (2023-03-01)

Effects of Hippocampal Sparing Radiotherapy on Brain Microstructure—A Diffusion Tensor Imaging Analysis
by: Johannes G. Dinkel, et al.
Published: (2022-07-01)

On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data.
by: Barbara Witulla, et al.
Published: (2020-01-01)

Gait and Cognition in Parkinson’s Disease: Cognitive Impairment Is Inadequately Reflected by Gait Performance during Dual Task
by: Heiko Gaßner, et al.
Published: (2017-10-01)

Turning Analysis during Standardized Test Using On-Shoe Wearable Sensors in Parkinson’s Disease
by: Nooshin Haji Ghassemi, et al.
Published: (2019-07-01)

The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
by: Sara Lorio, et al.
Published: (2019-03-01)

Pareidolia in Parkinson’s Disease and Multiple System Atrophy
by: Kentaro Kurumada, et al.
Published: (2021-01-01)

Distinct atrophy of septal nuclei in Parkinson’s disease
by: Niloufar Kamalkhani, et al.
Published: (2022-01-01)

Silent struggles: Parkinson’s disease with multiple system atrophy
by: Khasnur Abd Malek
Published: (2024-03-01)

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
by: Jia Wei Hor, et al.
Published: (2022-05-01)

Role of the adipocyte immune brain axis in Parkinson’s disease: friend or foe?
by: Martin Regensburger, et al.
Published: (2023-01-01)

Whole-Brain Atrophy Rate in Idiopathic Parkinson’s Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
by: C. Guevara, et al.
Published: (2016-01-01)

Asymmetrical putaminal atrophy in parkinsonism-predominant multiple system atrophy (MSA-P): A case report
by: Koichiro Mori, MD, et al.
Published: (2023-09-01)

Cholinergic basal forebrain atrophy in Parkinson's disease with freezing of gait
by: Caiting Gan, et al.
Published: (2023-05-01)

Semiautomated Algorithm for the Diagnosis of Multiple System Atrophy With Predominant Parkinsonism
by: Woong-Woo Lee, et al.
Published: (2022-09-01)

Body mass index and severity of parkinsonism in multiple system atrophy
by: Ai Suzuki, et al.
Published: (2017-09-01)

Brain Atrophy and Reorganization of Structural Network in Parkinson's Disease With Hemiparkinsonism
by: Xiaojun Xu, et al.
Published: (2018-03-01)

Network structure of brain atrophy in de novo Parkinson's disease
by: Yashar Zeighami, et al.
Published: (2015-09-01)

Adult Hippocampal Neurogenesis in Parkinson’s Disease: Impact on Neuronal Survival and Plasticity
by: Martin Regensburger, et al.
Published: (2014-01-01)

Chemical communication between phytopathogens, their host plants and vector insects and eavesdropping by natural enemies
by: Juergen Gross, et al.
Published: (2016-08-01)

Usefulness of Diffusion-Weighted MRI for Differentiation between Parkinson’s Disease and Parkinson Variant of Multiple System Atrophy
by: Eun Joo Chung, et al.
Published: (2009-10-01)

Patient perspectives on the use of digital medical devices and health data for AI-driven personalised medicine in Parkinson’s Disease
by: Ivana Paccoud, et al.
Published: (2024-12-01)

The differences of orthostatic hypotension in patients with Parkinson's disease and multiple system atrophy
by: Jingrong Zeng, et al.
Published: (2023-01-01)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
by: Lisa Fellner, et al.
Published: (2022-06-01)

Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson’s disease
by: Weifang Yin, et al.
Published: (2022-08-01)

Analysis on executive dysfunction of patients with multiple system atrophy and Parkinson's disease
by: Xu ZHANG, et al.
Published: (2016-05-01)

Differentiation of Parkinson’s disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging
by: Qingguo Ren, et al.
Published: (2022-08-01)

Deep brain stimulation in multiple system atrophy mimicking idiopathic Parkinson's disease.
by: Thavanesan, N, et al.
Published: (2014)

Risk willingness in multiple system atrophy and Parkinson’s disease understanding patient preferences
by: Alexander Maximilian Bernhardt, et al.
Published: (2024-08-01)

The role of α-synuclein prion strains in Parkinson's disease and multiple system atrophy.
by: Chase R Khedmatgozar, et al.
Published: (2024-01-01)

Strain-dependent alpha-synuclein spreading in Parkinson’s disease and multiple system atrophy
by: Shuyu Zhang, et al.
Published: (2024-01-01)

The role of α-synuclein prion strains in Parkinson’s disease and multiple system atrophy
by: Chase R. Khedmatgozar, et al.
Published: (2024-01-01)

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy
by: Michaela Kaiserova, et al.
Published: (2021-01-01)

Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
by: Paula Ramos-Gonzalez, et al.
Published: (2021-03-01)

Value of electrophysiological indicators in differential diagnosis of parkinson's disease and multiple system atrophy
by: Wangwang Hu, et al.
Published: (2023-03-01)